ConductScience.org, home

Paper24176554

Escaping the immune system: How the malaria parasite makes vaccine development a challenge.

Stanisic DI and 2 others. Trends Parasitol, 2013. Cited by 46 papers, by iCite.

Cite this record

ConductScience Library. Escaping the immune system: How the malaria parasite makes vaccine development a challenge. Papers, record 24176554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24176554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Escaping the immune system: How the malaria parasite makes vaccine development a challenge.
PubMed
Journal
Trends Parasitol
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
46
iCite
Relative citation ratio, by iCite
1.41
iCite
Revised in PubMed
2013-11-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stanisic DIDanielle I
2Barry AEAlyssa E
3Good MFMichael F

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Host-Parasite InteractionsMajor topic
Immune SystemMajor topic
MalariaMajor topic
Malaria VaccinesMajor topic
Animals
Humans
Plasmodium

Source PubMed

Download CSV of topics

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.

PMIDTitleJournalYearIn PapersSource
41208999Micro-geographic variation in antigenic diversity of PfEBA-175 region II in asymptomatic Plasmodium falciparum infections in Tanzania.Front Immunol2025https://conductscience.org/library/papers/41208999PubMed
41128014Extreme Genetic Diversity and Signatures of Balancing Selection in Plasmodium vivax Blood-Stage Antigens.J Infect Dis2026https://conductscience.org/library/papers/41128014PubMed
39759387Genetic diversity of Plasmodium vivax and Plasmodium falciparum field isolates from Honduras in the malaria elimination phase.Curr Res Parasitol Vector Borne Dis2025https://conductscience.org/library/papers/39759387PubMed
37728713Malaria Vaccines: Progress to Date.BioDrugs2023https://conductscience.org/library/papers/37728713PubMed
37684152Hiding in plain sight: an epitope-based strategy for a subunit malaria vaccine.Trends Parasitol2023https://conductscience.org/library/papers/37684152PubMed
37396303A conserved epitope in VAR2CSA is targeted by a cross-reactive antibody originating from Plasmodium vivax Duffy binding protein.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/37396303PubMed
36685595Host-parasite interactions during Plasmodium infection: Implications for immunotherapies.Front Immunol2022https://conductscience.org/library/papers/36685595PubMed
35349608Untangling population structure and genetic diversity of reticulocyte binding protein 2b (PvRBP2b) erythrocytic stage vaccine candidate in worldwide Plasmodium vivax isolates.PLoS One2022https://conductscience.org/library/papers/35349608PubMed
35108259Global diversity and balancing selection of 23 leading Plasmodium falciparum candidate vaccine antigens.PLoS Comput Biol2022https://conductscience.org/library/papers/35108259PubMed
34987497Plasmodium berghei-Released Factor, PbTIP, Modulates the Host Innate Immune Responses.Front Immunol2021https://conductscience.org/library/papers/34987497PubMed
32174924The Case for Exploiting Cross-Species Epitopes in Malaria Vaccine Design.Front Immunol2020https://conductscience.org/library/papers/32174924PubMed
32133407Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2.Sci Adv2020https://conductscience.org/library/papers/32133407PubMed
30538708Human Vγ9Vδ2 T Lymphocytes in the Immune Response to P. falciparum Infection.Front Immunol2018https://conductscience.org/library/papers/30538708PubMed
30479379Models of immune selection for multi-locus antigenic diversity of pathogens.Nat Rev Immunol2019https://conductscience.org/library/papers/30479379PubMed
30239833Plasmodium falciparum Activates CD16+ Dendritic Cells to Produce Tumor Necrosis Factor and Interleukin-10 in Subpatent Malaria.J Infect Dis2019https://conductscience.org/library/papers/30239833PubMed
29765991Immune Response and Evasion Mechanisms of Plasmodium falciparum Parasites.J Immunol Res2018https://conductscience.org/library/papers/29765991PubMed
29376476A bite to fight: front-line innate immune defenses against malaria parasites.Pathog Glob Health2018https://conductscience.org/library/papers/29376476PubMed
29162686Atypical activation of dendritic cells by Plasmodium falciparum.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/29162686PubMed
28161402The genome of the protozoan parasite Cystoisospora suis and a reverse vaccinology approach to identify vaccine candidates.Int J Parasitol2017https://conductscience.org/library/papers/28161402PubMed
27604988Characterization of fine specificity of the immune response to a Plasmodium falciparum rhoptry neck protein, PfAARP.Malar J2016https://conductscience.org/library/papers/27604988PubMed

See all 30 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24176554

GET https://conductscience.org/api/papers/v1/24176554/cited_by?page=2